HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prognostic evaluation of the absolute lymphopenia during prednisolone therapy of chronic pulmonary sarcoidosis (author's transl)].

Abstract
From a controlled prednisolone therapy trial 130 patients with chronic pulmonary sarcoidosis who had already finished their drug-therapy were evaluated. The relapse rate was 28.5% within the following two years. It is obvious, that the long-time prognosis of cases with very low absolute numbers of lymphocytes in the peripheral blood (1000 and less/mul) is significantly poorer than in all other cases.
AuthorsD Böttger
JournalZeitschrift fur Erkrankungen der Atmungsorgane (Z Erkr Atmungsorgane) Vol. 144 Issue 1 Pg. 39-44 ( 1976) ISSN: 0303-657X [Print] Germany
Vernacular TitleZur prognostischen Bedeutung der absoluten Lymphopenie unter der Prednisolontherapie der chronischen Lungensarkoidose
PMID969688 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Prednisolone
Topics
  • Chronic Disease
  • Humans
  • Lung Diseases (complications, drug therapy)
  • Lymphopenia (chemically induced, diagnosis)
  • Prednisolone (adverse effects, therapeutic use)
  • Prognosis
  • Recurrence
  • Sarcoidosis (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: